Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma
Clinical trial NCT03307759 · TERMINATED
Trial details
- NCT number
- NCT03307759
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-07
- Primary completion
- 2022-01-31
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.